BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26870892)

  • 1. RHAMM splice variants confer radiosensitivity in human breast cancer cell lines.
    Schütze A; Vogeley C; Gorges T; Twarock S; Butschan J; Babayan A; Klein D; Knauer SK; Metzen E; Müller V; Jendrossek V; Pantel K; Milde-Langosch K; Fischer JW; Röck K
    Oncotarget; 2016 Apr; 7(16):21428-40. PubMed ID: 26870892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.
    Shigeishi H; Fujimoto S; Hiraoka M; Ono S; Taki M; Ohta K; Higashikawa K; Kamata N
    Int J Oncol; 2009 Jun; 34(6):1565-71. PubMed ID: 19424574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia.
    Greiner J; Ringhoffer M; Taniguchi M; Schmitt A; Kirchner D; Krähn G; Heilmann V; Gschwend J; Bergmann L; Döhner H; Schmitt M
    Exp Hematol; 2002 Sep; 30(9):1029-35. PubMed ID: 12225794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bio-electric field enhancement: the influence on hyaluronan mediated motility receptors in human breast carcinoma.
    Purnell MC
    Discov Med; 2017 Apr; 23(127):259-267. PubMed ID: 28595038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma.
    Maxwell CA; Rasmussen E; Zhan F; Keats JJ; Adamia S; Strachan E; Crainie M; Walker R; Belch AR; Pilarski LM; Barlogie B; Shaughnessy J; Reiman T
    Blood; 2004 Aug; 104(4):1151-8. PubMed ID: 15105292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells.
    Assmann V; Marshall JF; Fieber C; Hofmann M; Hart IR
    J Cell Sci; 1998 Jun; 111 ( Pt 12)():1685-94. PubMed ID: 9601098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
    Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
    PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of sequence, protein isoforms, and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain.
    Lynn BD; Li X; Cattini PA; Turley EA; Nagy JI
    J Comp Neurol; 2001 Oct; 439(3):315-30. PubMed ID: 11596057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RHAMM (receptor hyaluronan-mediated motility)-target peptides induce apoptosis in prostate cancer cells].
    Akentieva NP; Shushanov SS
    Vopr Onkol; 2016; 62(3):514-8. PubMed ID: 30463110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants.
    Crainie M; Belch AR; Mant MJ; Pilarski LM
    Blood; 1999 Mar; 93(5):1684-96. PubMed ID: 10029598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells.
    Anastasov N; Höfig I; Vasconcellos IG; Rappl K; Braselmann H; Ludyga N; Auer G; Aubele M; Atkinson MJ
    Radiat Oncol; 2012 Dec; 7():206. PubMed ID: 23216894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.
    Wang D; Narula N; Azzopardi S; Smith RS; Nasar A; Altorki NK; Mittal V; Somwar R; Stiles BM; Du YN
    Oncotarget; 2016 Jun; 7(26):39957-39969. PubMed ID: 27220886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53.
    Sohr S; Engeland K
    Cell Cycle; 2008 Nov; 7(21):3448-60. PubMed ID: 18971636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
    Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
    Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
    Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
    J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose Ionizing Radiation Regulates Gene Expression Changes in the MCF7 Breast Cancer Cell Line.
    Bravatà V; Minafra L; Russo G; Forte GI; Cammarata FP; Ripamonti M; Casarino C; Augello G; Costantini F; Barbieri G; Messa C; Gilardi MC
    Anticancer Res; 2015 May; 35(5):2577-91. PubMed ID: 25964533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of BTG1 enhances the radiation sensitivity of human breast cancer in vitro and in vivo.
    Zhu R; Li W; Xu Y; Wan J; Zhang Z
    Oncol Rep; 2015 Dec; 34(6):3017-24. PubMed ID: 26503430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHAMM inhibits cell migration via the AKT/GSK3β/Snail axis in luminal A subtype breast cancer.
    Wang J; Li D; Shen W; Sun W; Gao R; Jiang P; Wang L; Liu Y; Chen Y; Zhou W; Wang R; Xiang R; Stupack D; Luo N
    Anat Rec (Hoboken); 2020 Sep; 303(9):2344-2356. PubMed ID: 31769593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.